We would like to thank our readers, subscribers and collaboration partners for a fruitful and eventful Q1 + Q2 2023, and we wish you all a most wonderful summer!

The next NLS Newsletter will be sent out on August 10, but our news feed and social media channels will continue to provide you with the latest news and in-depth stories from our exciting life science industry.

2023 has had a challenging start, not least financially, but we have also seen Nordic life science companies and researchers making great progress and announcing positive updates and results. Explore our site and archive and learn more about this spring’s major business deals, initiatives and events. You will find some of our most popular articles and interviews during the spring of 2023 here below.

We wish you all a relaxing summer!

The NLS team

7 x Vacation reading

1. “I fell in love with organic chemistry”

Carolyn Bertozzi took click chemistry to a new dimension when she started to utilize it in living organisms to map cells. This class of chemical reactions is called bioorthogonal chemistry and before Bertozzi’s development of them 22 years ago, researchers risked disturbing natural processes when observing molecules and their interactions in living beings.

Read Ellen Delisio’s interview with Nobel Laureate Carolyn Bertozzi here!

2. The status of Nordic clinical trials

Clinical trials play a crucial role in advancing medical research and bringing new and innovative treatments to the market. The Nordic region is known for its strong life science research and development, as well as unique health data. Performing clinical trials in the region is not without its challenges, but these can be overcome through improved collaboration and new technologies.

Read Howard Bennett’s in-depth article here!

3. Sobi to acquire CTI BioPharma for 1.7 billion USD

“The acquisition of CTI is the latest in a series of transformative transactions Sobi has conducted to build its leading rare haematology franchise,” says Guido Oelkers President and CEO of Sobi.

Read about the business deal here!

4. R.I.P. Jantelagen

A reflection around the importance of aiming high in times of economic turmoil.

Read Helena Strigård’s column here!

5. A district for solving future challenges

Norway’s first innovation district is taking shape in Oslo and when completed, the capital will also host the country’s largest life science building.

Read the article here!

6. “Although the war has affected me a lot, I will not lose heart!”

Hello, my name is Anatolii Kovalchuk, and I am a remote developer from Ukraine. This is the story of my experience working for a European startup during the war.

Read Anatolii’s perspective here!

7. Following a compound from start to finish

Anders Findsen likes to be part of the different R&D aspects of an up-and-coming dynamic biotech company. As Research Scientist at NMD Pharma he gets to follow a compound from the beginning to hopefully going into the clinic in the end.

Read the careers interview with Anders Findsen here!